Mesoblast Sets Ryoncil® Price Based on Economic Value of – GlobeNewswire

Rexlemestrocel-L has received RMAT designation from FDA for the treatment of chronic low back pain. Details of Financial Results for Half-Year Ended …
Source: back pain